Largest Shareholder Dong-gi Lee's Stake Slightly Decreases from 17.14% to 16.93% Due to Off-Market Sales and Executive Resignation


  • The largest shareholder Dong-gi Lee and his special relations reduced their total shareholding by 28,333 shares, causing the holding ratio to decrease from 17.14% to 16.93% (a drop of 0.21 percentage points).
  • Reasons for the decrease include: off-market sale of 33,333 shares by Lee, on-market sales of 4,000 shares by special relation Gongsun, and exclusion of former executive Park Shin-young as a special relation (40,000 shares removed).
  • Some executives (e.g., Kang Chung-gil, Park Jun-hyun) increased their holdings through stock option exercises and grants, but the net change was negative.
  • Total voting shares outstanding increased from 22,169,230 to 22,301,830 due to stock option exercises.
  • Lee's personal shareholding decreased by 33,333 shares from 3,364,160 to 3,330,827, with an average sale price of KRW 149,578.
  • [AI Summary]The largest shareholder's slight stake reduction and changes in special relations have marginally lowered the holding ratio, but the impact on management control is limited. However, continued stake reduction could be perceived as a negative signal, warranting investor attention.

KOSDAQ Filing Information


  • Filing: Report on Large Shareholding (General)
  • Company: OliX Pharmaceuticals (226950)
  • Submission: Dong-gi Lee
  • Receipt: 06-01-2026